Company Analysis

Ascendis Pharma A/S (ASND)

Nasdaq: ASND · Pharmaceutical Preparations · filing with the SEC since 2014
Grade6.2
◀ Past 7.0● Present 6.0▶ Future 5.5
2 est.

Income statement, as filed

In thousands of euros (EUR), as filed; per-share figures in euros; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 11, 2026Feb 12, 2025Feb 7, 2024Feb 16, 2023Mar 2, 2022Mar 10, 2021Apr 3, 2020Apr 3, 2019Mar 28, 2018Mar 22, 2017
Revenue720,132363,641266,71851,1747,7786,95313,37510,5811,5304,606
Cost of revenue94,91544,25844,39512,1373,52300···
Gross profit625,217319,383222,32339,0374,2556,95313,375···
Research and development303,621307,004413,454379,624295,867260,904191,621140,28199,58966,022
Selling, general and administrative457,867291,142264,410221,227160,18076,66948,47325,05713,48211,504
Operating income-136,271-278,763-455,541-561,814-451,792-330,620-226,719-154,757-111,541-72,920
Finance costs206,687100,02744,06550,4873,91180,8421,22112713,7563,112
Finance income113,99925,60943,85752,18159,7181,81217,80324,7149237,300
Share of profit of equity-method investments16,308-20,060-18,395-17,69712,041-9,524-8,113-321··
Income before income taxes-212,651-373,241-474,144-577,817-383,944-419,174-218,250-130,491-124,374-68,732
Income tax expense15,3834,8437,3035,377-367-219-234-394-477-227
Income from continuing operations········-123,897-68,505
Net income-228,034-378,084-481,447-583,194-383,577-418,955-218,016-130,097-123,897-68,505
Net income to shareholders-228,034-378,084-481,447-583,194-383,577-418,955-218,016-130,097··
Earnings per share, basic-3.76-6.53-8.55-10.40-7.00···-3.68-2.58
Earnings per share, diluted-3.76-6.53-8.55-10.40-7.00···-3.68-2.58
Earnings per share, basic and diluted·····-8.28-4.69-3.17-3.68-2.58
Weighted average shares, basic60,607,13157,891,57056,287,06056,071,79354,771,76350,616,52846,506,86241,085,23733,626,30526,564,414
Weighted average shares, diluted········33,626,30526,564,414
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Share of profit of equity-method investments its share of companies it partly ownsifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton ASND · research, not advice